These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32351561)

  • 41. Total thyroidectomy vs completion thyroidectomy for thyroid nodules with indeterminate cytology/follicular proliferation: a single-centre experience.
    Sena G; Gallo G; Innaro N; Laquatra N; Tolone M; Sacco R; Sammarco G
    BMC Surg; 2019 Jul; 19(1):87. PubMed ID: 31291921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preoperative Role of RAS or BRAF K601E in the Guidance of Surgery for Indeterminate Thyroid Nodules.
    Ravella L; Lopez J; Descotes F; Giai J; Lapras V; Denier ML; Borson-Chazot F; Lifante JC; Decaussin-Petrucci M
    World J Surg; 2020 Jul; 44(7):2264-2271. PubMed ID: 32227276
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.
    Adeniran AJ; Hui P; Chhieng DC; Prasad ML; Schofield K; Theoharis C
    Acta Cytol; 2011; 55(6):570-5. PubMed ID: 22156468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Value of
    Chen X; Zhou Q; Wang F; Zhang F; Du H; Zhang Q; Wu W; Gong X
    AJNR Am J Neuroradiol; 2018 Dec; 39(12):2360-2365. PubMed ID: 30498021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Follicular neoplasm involving one lobe of thyroid: is hemithyroidectomy the adequate initial procedure?
    Pradeep PV; Vissa S
    Ir J Med Sci; 2013 Mar; 182(1):37-40. PubMed ID: 22492024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
    Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
    Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular testing of BRAF, RAS and TERT on thyroid FNAs with indeterminate cytology improves diagnostic accuracy.
    Decaussin-Petrucci M; Descotes F; Depaepe L; Lapras V; Denier ML; Borson-Chazot F; Lifante JC; Lopez J
    Cytopathology; 2017 Dec; 28(6):482-487. PubMed ID: 29094776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of benign gene expression classifier test results on the endocrinologist-patient decision to operate on patients with thyroid nodules with indeterminate fine-needle aspiration cytopathology.
    Duick DS; Klopper JP; Diggans JC; Friedman L; Kennedy GC; Lanman RB; McIver B
    Thyroid; 2012 Oct; 22(10):996-1001. PubMed ID: 22873825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of molecular testing in fine-needle aspiration biopsy samples: an experience in a Chinese population.
    Liu S; Gao A; Zhang B; Zhang Z; Zhao Y; Chen P; Ji M; Hou P; Shi B
    Exp Mol Pathol; 2014 Oct; 97(2):292-7. PubMed ID: 25111330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
    Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
    Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective Study of Bethesda Categories III and IV Thyroid Nodules: Outcomes and Predictive Value of BRAF
    Chirayath SR; Pavithran PV; Abraham N; Nair V; Bhavani N; Kumar H; Menon UV; Menon AS
    Indian J Endocrinol Metab; 2019; 23(3):278-281. PubMed ID: 31641627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk stratification of indeterminate thyroid fine-needle aspiration biopsy specimens based on mutation analysis.
    Filicori F; Keutgen XM; Buitrago D; AlDailami H; Crowley M; Fahey TJ; Zarnegar R
    Surgery; 2011 Dec; 150(6):1085-91. PubMed ID: 22136825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular testing in the diagnosis of differentiated thyroid carcinomas.
    Ferrari SM; Fallahi P; Ruffilli I; Elia G; Ragusa F; Paparo SR; Ulisse S; Baldini E; Giannini R; Miccoli P; Antonelli A; Basolo F
    Gland Surg; 2018 Aug; 7(Suppl 1):S19-S29. PubMed ID: 30175060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens.
    Kelman AS; Rathan A; Leibowitz J; Burstein DE; Haber RS
    Thyroid; 2001 Mar; 11(3):271-7. PubMed ID: 11327619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective study.
    Chiofalo MG; Signoriello S; Fulciniti F; Avenia N; Ristagno S; Lombardi CP; Nicolosi A; Pelizzo MR; Perigli G; Polistena A; Panebianco V; Bellantone R; Calò PG; Boschin IM; Badii B; Di Maio M; Gallo C; Perrone F; Pezzullo L
    Endocrine; 2018 Jul; 61(1):43-50. PubMed ID: 29569123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery.
    De Napoli L; Bakkar S; Ambrosini CE; Materazzi G; Proietti A; Macerola E; Basolo F; Miccoli P
    Thyroid; 2016 Mar; 26(3):390-4. PubMed ID: 26548748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. BRAF mutation analysis in thyroid nodules with indeterminate cytology: our experience on surgical management of patients with thyroid nodules from an area of borderline iodine deficiency.
    Agretti P; Niccolai F; Rago T; De Marco G; Molinaro A; Scutari M; Di Cosmo C; Di Coscio G; Vitale M; Maccheroni M; Vitti P; Tonacchera M
    J Endocrinol Invest; 2014 Oct; 37(10):1009-14. PubMed ID: 25194426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Malignancy Rates in Thyroid Nodules: How to Counsel Patients on Extent of Surgery.
    Lindeman BM; Nehs MA; Angell TE; Alexander EK; Gawande AA; Moore FD; Doherty GM; Cho NL
    Ann Surg Oncol; 2019 Jan; 26(1):93-97. PubMed ID: 30341576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does frozen section have a role in the intraoperative management of thyroid nodules?
    Cheng MS; Morgan JL; Serpell JW
    ANZ J Surg; 2002 Aug; 72(8):570-2. PubMed ID: 12190731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology.
    Cantara S; Capezzone M; Marchisotta S; Capuano S; Busonero G; Toti P; Di Santo A; Caruso G; Carli AF; Brilli L; Montanaro A; Pacini F
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1365-9. PubMed ID: 20130073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.